Medicine & Life Sciences
Doxorubicin
43%
Dexrazoxane
42%
Breast Neoplasms
42%
Trastuzumab
31%
Deoxyglucose
30%
Pharmaceutical Preparations
27%
Metformin
14%
Angiotensin-Converting Enzyme Inhibitors
13%
Therapeutics
10%
Carvedilol
9%
Antibodies, Monoclonal, Humanized
8%
Enalapril
8%
thiazolyl blue
8%
Anthracyclines
7%
Cardiotoxicity
7%
Antineoplastic Agents
6%
Cell Survival
5%
Phosphorylation
4%
Cell Line
3%
Drug Therapy
3%
Chemical Compounds
Cardioprotective
100%
Doxorubicin
46%
Drug
35%
Metformin
21%
Angiotensin-Converting Enzyme Inhibitor
20%
Enalapril
11%
Carvedilol
11%
Anthracycline
9%
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide
9%
Antidiabetic Agent
9%
Cell Viability
7%
Antineoplastic Agent
6%
Dose
5%